Inventor · disambiguated record
Matthew Heil
Also filed as: HEIL MATTHEW · HEIL MATTHEW F
23 granted patents·24 pending applications·333 citations·filing 1998–2025
96Inventor score
Top patents by PatentIndex Score
47 records- 0197US9492515B2Method of treatment of schizophreniform disorderCUREMARK LLC·Filed 2015·Granted Nov 15, 2016·27 cites·17 claims
- 0297US9107419B2Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfacesFALLON JOAN M·Filed 2010·Granted Aug 18, 2015·44 cites·16 claims
- 0397US9084784B2Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfacesFALLON JOAN M·Filed 2010·Granted Jul 21, 2015·41 cites·19 claims
- 0496US10279016B2Method of treatment of schizophreniform disorderCUREMARK LLC·Filed 2016·Granted May 7, 2019·9 cites·22 claims
- 0596US10098844B2Enzyme delivery systems and methods of preparation and useCUREMARK LLC·Filed 2015·Granted Oct 16, 2018·14 cites·30 claims
- 0696US8980252B2Methods of treatment of schizophreniaFALLON JOAN·Filed 2012·Granted Mar 17, 2015·42 cites·13 claims
- 0794US9931302B2Enzyme delivery systems and methods of preparation and useCUREMARK LLC·Filed 2015·Granted Apr 3, 2018·10 cites·28 claims
- 0894US9511125B2Methods and compositions for the treatment of influenzaFALLON JOAN M·Filed 2010·Granted Dec 6, 2016·13 cites·20 claims
- 0993US11419821B2Enzyme delivery systems and methods of preparation and useCUREMARK LLC·Filed 2018·Granted Aug 23, 2022·3 cites·26 claims
- 1093US10940187B2Method of treatment of schizophreniform disorderCUREMARK LLC·Filed 2019·Granted Mar 9, 2021·4 cites·20 claims
- 1191US9895427B2Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfacesGALENAGEN LLC·Filed 2015·Granted Feb 20, 2018·10 cites·22 claims
- 1290US10716835B2Methods and compositions for the prevention and treatment of influenzaCUREMARK LLC·Filed 2016·Granted Jul 21, 2020·3 cites·27 claims
- 1388US10350278B2Methods of treating Celiac diseaseCUREMARK LLC·Filed 2013·Granted Jul 16, 2019·8 cites·10 claims
- 1488US9687452B2Enzyme delivery systems and methods of preparation and useCUREMARK LLC·Filed 2015·Granted Jun 27, 2017·4 cites·78 claims
- 1586US11364287B2Methods of treating celiac diseaseCUREMARK LLC·Filed 2019·Granted Jun 21, 2022·1 cites·11 claims
- 1685US9415014B2Enzyme delivery systems and methods of preparation and useFALLON JOAN M·Filed 2011·Granted Aug 16, 2016·4 cites·65 claims
- 1784US2022347101A1Enzyme delivery systems and methods of preparation and useCUREMARK LLC·Filed 2022·Application pending·0 cites
- 1884US2024156924A1Method of treating schizophrenia or schizophreniform disorderCUREMARK LLC·Filed 2023·Application pending·0 cites
- 1984US2024245761A1Methods of treating celiac diseaseCUREMARK LLC·Filed 2024·Application pending·0 cites
- 2082US6013622AMethod of regulating appetite and metabolismNUTRICEUTICAL TECHNOLOGY CORP·Filed 1998·Granted Jan 11, 2000·87 cites·32 claims
- 2181US10776453B2Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic painFALLON JOAN M·Filed 2009·Granted Sep 15, 2020·8 cites·90 claims
- 2280US12485094B2Methods of prophylaxis of coronavirus infection and treatment of coronavirusesCUREMARK LLC·Filed 2022·Granted Dec 2, 2025·0 cites·19 claims
- 2377US2022273777A1Methods of treating celiac diseaseCUREMARK LLC·Filed 2022·Application pending·0 cites
- 2474US11541009B2Methods of prophylaxis of coronavirus infection and treatment of coronavirusesCUREMARK LLC·Filed 2021·Granted Jan 3, 2023·0 cites·17 claims
- 2574US2021145947A1Method of treating schizophrenia or schizophreniform disorderCUREMARK LLC·Filed 2021·Application pending·0 cites
- 2672US10736946B2Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfacesGALENAGEN LLC·Filed 2015·Granted Aug 11, 2020·1 cites·18 claims
- 2772US2010063084A1Multi-phase release methscopolamine compositionsHEIL MATTHEW F·Filed 2009·Application pending·0 cites
- 2866US12226464B2Compositions for treating addictionCUREMARK LLC·Filed 2018·Granted Feb 18, 2025·0 cites·35 claims
- 2966US2020323965A1Compositions and methods for treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfacesGALENAGEN LLC·Filed 2020·Application pending·0 cites
- 3065US2021162024A1Methods of treating behavioral symptoms of neurological and mental disordersCUREMARK LLC·Filed 2020·Application pending·0 cites
- 3165US2008064694A1Multi-Phase Release Methscopolamine CompositionsAURIGA LAB INC·Filed 2007·Application pending·0 cites
- 3264US2013113129A1Enzyme Delivery Systems and Methods of Preparation and UseFALLON JOAN M·Filed 2012·Application pending·0 cites
- 3364US2020282030A1Methods and Compositions for the Prevention and Treatment of InfluenzaCUREMARK LLC·Filed 2020·Application pending·0 cites
- 3462US2012189703A1Enzyme Delivery Systems and Methods of Preparation and UseFALLON JOAN M·Filed 2012·Application pending·0 cites
- 3562US2020286620A1Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of parkinsons disease, movement and neurological disorders, and chronic painGALENAGEN LLC·Filed 2020·Application pending·0 cites
- 3661US2010041759A1Multi-phase release potassium guaiacolsulfonate compositionsWILSON GLYNN·Filed 2009·Application pending·0 cites
- 3761US2025367271A1Compositions for treating addictionCUREMARK LLC·Filed 2025·Application pending·0 cites
- 3861US2022096611A1Enzyme compositions and use thereof for wound healingGALENAGEN LLC·Filed 2021·Application pending·0 cites
- 3959US2018243282A1Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery SystemsCUREMARK LLC·Filed 2018·Application pending·0 cites
- 4058US11357835B2Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfacesGALENAGEN LLC·Filed 2017·Granted Jun 14, 2022·0 cites·23 claims
- 4158US2013202581A1Enzyme compositions and use thereof for wound healingCURELON LLC·Filed 2013·Application pending·0 cites
- 4258US2009317487A1Kits for prevention and treatment of rhinitisHALL MISCHELLE·Filed 2009·Application pending·0 cites
- 4355US2013224172A1Methods of treating behavioral symptoms of neurological and mental disordersCUREMARK LLC·Filed 2013·Application pending·0 cites
- 4455US2007141147A1Sequential release pharmaceutical formulationsAURIGA LAB INC·Filed 2006·Application pending·0 cites
- 4554US2008085312A1Multi-Phase Release Potassium Guaiacolsulfonate CompositionsAURIGA LAB INC·Filed 2007·Application pending·0 cites
- 4653US2014147500A1Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery SystemsFALLON JOAN M·Filed 2010·Application pending·0 cites
- 4751US2008069874A1Kits for Prevention and Treatment of RhinitisAURIGA LAB INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Heil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →